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Tetanus is a disease caused by the deadly toxin tetanospasmin from Clostridium tetani. It is largely preventable but still remains a major public health 
problem in the developing world and is associated with high 
morbidity and mortality rates [1]. Annual global mortality was 
estimated at 213,000. A total of 198 deaths occurred in children 
below the age of 5 years [2]. Basher documented a mortality 
rate of 20% [3]. Anah et al. reported that post-neonatal tetanus 
accounted for 3.7% of childhood death, with a case fatality rate 
of 18% among hospitalized children in Nigeria [4]. Oyelami 
et al. [5] and Fatunde and Familusi [6] reported a case fatality 
rate of 39% and 37.5% among children. The most common cause 
of mortality in individuals with severe tetanus in the absence 
of mechanical ventilation is spasm-related respiratory failure, 
whereas in ventilated patients, it is tetanus-associated autonomic 
dysfunction [7].
Autonomic nervous system (NS) instability as a complication 
of tetanus is well documented. Features of autonomic insufficiency 
include tachycardia/bradycardia, oropharyngeal hypersecretion, 
excess sweating, and urinary retention. Hyperpyrexia, persistent 
hypertension, cardiac arrhythmias, and “autonomic storms” 
(marked cardiovascular instability leading to sudden cardiac 
death) are serious autonomic manifestations [8-10]. These have 
been attributed to high catecholamine levels due to the over 
activity of the sympathetic NS and direct effect of the tetanus 
toxin on the myocardium, whereas parasympathetic dysfunction 
is probably due to direct damage to the vagal nucleus by the 
tetanus toxin [10,11].
The supportive care in the intensive care unit (ICU) is one 
of the key principles in the treatment for tetanus but has its 
own drawbacks [10]. Deaths from this disease commonly occur 
within the 1st week of admission. Magnesium affects both the 
pre-synaptic and post-synaptic terminals of the sympathetic and 
parasympathetic neurons, competitively blocking calcium entry 
into the presynaptic terminals, thus impairing neuromuscular 
transmission by reducing acetylcholine release and it 
decreases the postsynaptic sensitivity of the motor endplate to 
acetylcholine [12].
Magnesium sulfate is safe to be used and also reduces the 
need for sedation and artificial ventilation in severe tetanus 
patients, thus contributing to survival benefits. Magnesium sulfate 
has been solely used previously for the control of autonomic 
dysfunction, muscle spasms, and rigidity associated with severe 
tetanus [13-15]. However, a few authors found it ineffective in 
the treatment of the severe form of the disease [16,17], while 
few others reported that patients treated with the combination of 
diazepam and magnesium sulfate had better outcome than those 
managed with diazepam only [11,17].
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CASE REPORT
We report two cases of male adolescents admitted in the 
department of pediatrics of the tertiary hospital of Nigeria for 
severe tetanus following an open injury to the limbs. Due to 
poor response to initial management with the combination of 
chlorpromazine, phenobarbitone, and diazepam, the latter 
was replaced with continuous infusion of magnesium sulfate 
after a loading dose was administered. Both the patients 
recovered without any prevailing complications, received 
tetanus toxoid and were discharged after 26 and 50 days of 
hospitalization, respectively, and were subsequently followed 
up. Written informed consent was obtained from the patient’s 
legal guardian(s) for publication of this case report and any 
accompanying images.
Case 1
A 14-year-old boy brought to the children emergency room 
with the complaint of inability to open the mouth followed 
3 days later by unprovoked generalized jerking of the body. 
There was no history of headache, loss of consciousness, 
antecedent irrational talk, behavior or head trauma, or ingestion 
of any substance. The patient was non-epileptic but had 
sustained an injury on his right forearm after being spanked 
with a bunch of broomsticks by the elder brother, 8 days before 
manifestation of these symptoms. The patient first took some 
herbal medications, but on deterioration of his condition, he 
was brought to our hospital. There was no history of previous 
immunization.
Examination on admission revealed a conscious patient, with 
unprovoked, intermittent, and painful spasms lasting for 1–2 min. 
There was trismus and abdominal rigidity. The pupils were of 
normal size reacting equally to light. Lumbar puncture could not 
be done due to recurrent unprovoked spasms. A clinical diagnosis 
of severe generalized tetanus was made using Udwadia’s 
prognostic classification [18].
On investigations, complete hemogram was normal. 
Electrolytes, urea, creatinine, and calcium levels were within 
normal limits. Liver function test was normal. He was 
started on intravenous crystalline penicillin, metronidazole, 
phenobarbitone, chlorpromazine, and diazepam for breakthrough 
spasms. The patient also received 20,000 IU of anti-tetanus 
serum (ATS) to neutralize unbound tetanus toxin. Tetanus 
immunoglobulin was not given because it was unavailable. 
The wound on the forearm was debrided and dressed daily 
using honey. Feeding through nasogastric tube was avoided 
to minimize risk of aspiration. Euglycemic state was therefore 
maintained through intravenous infusion of 5% dextrose saline 
with vitamin B complex injection.
Six days into admission, unprovoked severe spasms continued 
unabated despite adequate doses of phenobarbitone and 
chlorpromazine. Temperature chart showed spikes between 38 °C 
and 39°C. Tachycardia and tachypnea were prominent features. 
Blood pressure fluctuated between normal, low, and high levels. 
The patient was also found to have developed pressure sores on 
the buttocks.
In view of this poor response to the initial treatment protocol 
and the presence of autonomic dysfunction, magnesium sulfate 
was therefore added to phenobarbitone and chlorpromazine 
while diazepam was discontinued. A loading dose of 3 g was first 
given followed by continuous infusion of 100 mg/kg/h. Serial 
patellar reflex was done to monitor toxicity since we could not 
monitor the blood level of magnesium sulfate. The patient was 
also transferred to an improvised water bed (bags of locally made 
sachet water neatly and tightly arranged on the hospital bed) to 
avoid further development of pressure sores.
Five days after introducing this new protocol, spasms reduced 
markedly and vital signs stabilized. Spasms completely abated on 
the 15th day of commencement of magnesium sulfate with patient 
able to sit out of bed as well as mobilize with support. The patient 
stayed for 50 days on admission in the hospital to enable complete 
healing of pressure sores and he received a dose of tetanus on 
discharge and encouraged to return for catch-up immunization.
Case 2
A 14-year-old schoolboy presented with inability to open the 
mouth for 2 days followed by jerking of the body 5 days later. 
The patient sustained a bamboo stick injury on his big toe 6 days 
before the development of the first symptom. There was no loss 
of consciousness or antecedent head injury. Jerking of the body 
was unprovoked and was said to involve the whole body. The 
child did not receive any childhood immunization. He was first 
taken to a general hospital from where he was referred to the 
emergency room of the medical center.
Examination on presentation revealed a conscious child with 
intermittent, unprovoked, painful spasms, and trismus. There 
was abdominal rigidity; tachypnea and tachycardia. The blood 
pressure was elevated and the rectal temperature was 38.7°C. 
Examination of the right foot showed a necrotic ulcer on the 
plantar surface of the big toe. A diagnosis of severe tetanus 
was made using Udwadia’s prognostic classification [18]. Full 
blood count showed normal hemogram with normal serum 
electrolytes, urea, creatinine, and ionized calcium. Liver function 
test was normal. Lumbar puncture was not done to avoid further 
provocation of spasms.
The patient was admitted to a quiet isolation room and nursed 
on improvised water bed as described in case 1. Nasogastric tube 
feeding was avoided too, but euglycemic state was maintained with 
5% dextrose saline. The patient commenced on chlorpromazine, 
phenobarbitone, and diazepam for breakthrough spasms. He also 
received crystalline penicillin, Flagyl, and 20,000 IU of ATS to 
neutralize unbound tetanus toxin. Tetanus immunoglobulin was 
not given (was unavailable). Oxygen saturation during spasms 
ranged between 86% and 90% and in between spasms ranged 
between 96% and 98%. The patient was neither intubated nor had 
a tracheostomy done.
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Vital signs remained unstable as temperature spikes, ranging 
between 38.6°C and 39°C with unprovoked intermittent spasm 
persisting. On the 3rd day of admission, magnesium sulfate was 
added to chlorpromazine and phenobarbitone while diazepam 
was withdrawn, receiving a loading dose of 3 g infused into 
5% dextrose saline and given over 30 min. This was followed 
by continuous infusion of 100 mg/kg/h, monitoring magnesium 
sulfate toxicity by performing serial patellar reflex.
Spasms significantly reduced to 2 in number/24 h mainly 
on provocation (during blood pressure check), 48 h after 
commencement of magnesium sulfate. The blood pressure and 
other vital signs normalized. By 16th day on admission, patient 
was able to take both liquid and semisolid feeds, sit out of bed, 
and mobilize with support. He was discharged home on the 
26th day on admission after receiving a dose of tetanus toxoid and 
was encouraged to return for catch-up immunization.
DISCUSSION
The prognosis for severe tetanus characterized by severe spasms 
and autonomic dysfunction is poor [11,19]. Our patients who 
were managed for severe tetanus were neither immunized nor 
received booster doses of tetanus toxoid. This is in accordance 
with the previous studies where it was observed that post-neonatal 
tetanus occurs mostly in children who were not immunized 
against tetanus or those who received incomplete immunization 
during the 1st year of life [20,21]. The incubation period of the 
disease for our patients was short. Severity of the disease has 
been shown to be closely related to incubation period. Cook 
et al. [8] documented that shorter incubation period is associated 
with severe disease while a longer incubation period results in 
milder disease.
The portal of entry for one of our patients was a dirty 
wound on the lower limb. Oyelami et al. [5], Animasahun 
et al. [22], and Onwuekwe et al. [23] documented that lower 
limb injuries are the commonest portal of entry. This may 
be due to the fact that most adolescents in the rural setting 
remain without protective footwears. Autonomic dysfunction 
such as tachycardia, tachypnea, fluctuating blood pressure, 
and elevated body temperature are features of severe disease 
and poor prognosis [24]. Frequent, unprovoked spasms which 
may involve the respiratory muscles can cause death in non-
ventilated patients.
Magnesium sulfate has been found to mitigate the effect of 
autonomic dysfunction in tetanus patients [11,15,17]. The rapid 
control of spasms and autonomic dysfunction in our patients by 
magnesium sulfate shows its effectiveness in the management of 
severe tetanus. Shanbag et al. [16] similarly infused magnesium 
sulfate. The respiratory insufficiency associated with spasms 
also resolved with the use of magnesium sulfate obviating the 
need for intubation, tracheostomy, or respiratory support. Similar 
observations were made by Ceneviva et al. [1]. This is of utmost 
interest for resource-poor economies where ICU management of 
these patients appears to pose a great financial challenge.
CONCLUSION
Tetanus is still prevalent in rural communities especially among 
the unimmunized and severe forms could be managed with 
positive results using magnesium sulfate infusion which can be 
easily procured and is highly affordable.
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